Testing effectiveness (Phase 2)Study completedNCT00642148
What this trial is testing
A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 306